Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene ...

Reeling from the deaths of two patients who took Duchenne muscular dystrophy gene therapy Elevidys, Sarepta is launching a ...

Sarepta Therapeutics is laying off 500 staffers, or 36% of its workforce, as part of a strategic restructuring aiming to save $400 million annually. | Sarepta Therapeutics has laid off 500 staffers, ...

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) between ...

Intel CEO Deliberates Major Manufacturing Overhaul – and Possibly Losing Billions of Dollars Your email has been sent Why Intel’s CEO is concerned about the 18A chipmaking process What happens ...

Diversity Works New Zealand has undergone a structural reset to become Te Uru Tāngata Centre for Workplace Inclusion Chief Executive Maretha Smit said the change is not just a rebrand for one of the ...

Home Health today's big question Labour's NHS overhaul: is 10-year plan just what the doctor ordered? Keir Starmer announces reforms that promise to move NHS in England from a 'sickness service ...

The rebranding effort seeks to establish “consistent branding" across all State Department programs and offices to best reflect American contributions abroad, according to the agency.

Review Sarepta Therapeutics Inc (1SRPT:XMIL) stock and the current sustainability and ESG risk rating to help with your investing decisions.

Goodlettsville announces an organizational overhaul, merging departments to streamline governance and service delivery after a two-year operational evaluation.